In part 2 of a multi-part series, David Schoneker, president, Black Diamond Regulatory Consulting, explains what drives the ...
Stuart Tindal and David Chau discuss spectroscopic sensor selection for continuous bioprocessing and how industry ...
Richard Sanderson, IPS, discusses pharma capital project cost pressures, bloated deliverable lists, and making the case for ...
Rich Sanderson is Regional Operations Director for IPS in Pennsylvania. Rich brings extensive EPCM experience and almost ...
At INTERPHEX 2026, Mel Radford, Bethany Silva, and Jason Pennington explore data trust, cybersecurity, organizational ...
At INTERPHEX 2026, Bryan Poltilove highlights a novel technology as a promising point-of-use media manufacturing approach ...
Leslie Weaver and George Hunt, IPS, discuss early sustainability and lean alignment in pharma construction that reduce costs, ...
Leslie Weaver and George Hunt, IPS, discuss early sustainability and lean alignment in pharma construction that reduce costs, ...
George Hunt, IPS, discuss early sustainability and lean alignment in pharma construction that reduce costs, absorb ...
At INTERPHEX 2026, George Kwiecinski examines FDA GMP inspection trends, supplier oversight gaps, and the rising regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results